{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:01:54Z","timestamp":1760299314367,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":49,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493933457"},{"type":"electronic","value":"9781493933471"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3347-1_7","type":"book-chapter","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T09:04:49Z","timestamp":1456304689000},"page":"87-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter"],"prefix":"10.1007","author":[{"given":"Ana","family":"Armada","sequence":"first","affiliation":[]},{"given":"C\u00e9lia","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Gabriella","family":"Spengler","sequence":"additional","affiliation":[]},{"given":"Joseph","family":"Molnar","sequence":"additional","affiliation":[]},{"given":"Leonard","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio Sebasti\u00e3o","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.biotechadv.2013.06.004","volume":"31","author":"M Saraswathy","year":"2013","unstructured":"Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31:1397\u20131407","journal-title":"Biotechnol Adv"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","volume":"14","author":"M Dean","year":"2009","unstructured":"Dean M (2009) ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14:3\u20139","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/10915810600746023","volume":"25","author":"S Choudhuri","year":"2006","unstructured":"Choudhuri S, Klaassen CD (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25:231\u2013259","journal-title":"Int J Toxicol"},{"key":"7_CR4","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"LS Goodman","year":"2001","unstructured":"Goodman LS, Hardman JG, Limbird LE, Gilman AG (2001) Goodman & Gilman\u2019s the pharmacological basis of therapeutics. McGraw-Hill, New York"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1349-7006.2007.00538.x","volume":"98","author":"Y Kimura","year":"2007","unstructured":"Kimura Y, Morita SY, Matsuo M, Ueda K (2007) Mechanism of multidrug recognition by MDR1\/ABCB1. Cancer Sci 98:1303\u20131310","journal-title":"Cancer Sci"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nature05630","volume":"446","author":"CF Higgins","year":"2007","unstructured":"Higgins CF (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature 446:749\u2013757","journal-title":"Nature"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","volume":"86","author":"B Sarkadi","year":"2006","unstructured":"Sarkadi B, Homolya L, Szakacs G, Varadi A (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86:1179\u20131236","journal-title":"Physiol Rev"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.1021\/bi970553v","volume":"36","author":"Y Taguchi","year":"1997","unstructured":"Taguchi Y, Kino K, Morishima M, Komano T, Kane SE, Ueda K (1997) Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1\/P-glycoprotein. Biochemistry 36:8883\u20138889","journal-title":"Biochemistry"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.acthis.2008.11.010","volume":"111","author":"J Molnar","year":"2009","unstructured":"Molnar J, Kars MD, Gunduz U, Engi H, Schumacher U, Van Damme EJ, Peumans WJ, Makovitzky J, Gyemant N, Molnar P (2009) Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Acta Histochem 111:329\u2013333","journal-title":"Acta Histochem"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152\u2013162","journal-title":"Biochim Biophys Acta"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","volume":"62","author":"MM Gottesman","year":"1993","unstructured":"Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385\u2013427","journal-title":"Annu Rev Biochem"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361\u2013398","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"13686","DOI":"10.1021\/bi801409r","volume":"47","author":"PD Eckford","year":"2008","unstructured":"Eckford PD, Sharom FJ (2008) Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. Biochemistry 47:13686\u201313698","journal-title":"Biochemistry"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0098-2997(94)00040-A","volume":"16","author":"C Shustik","year":"1995","unstructured":"Shustik C, Dalton W, Gros P (1995) P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation. Mol Aspects Med 16:1\u201378","journal-title":"Mol Aspects Med"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fonc.2014.00041","volume":"4","author":"FJ Sharom","year":"2014","unstructured":"Sharom FJ (2014) Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function. Front Oncol 4:41","journal-title":"Front Oncol"},{"key":"7_CR16","first-page":"137","volume":"2","author":"K Yang","year":"2008","unstructured":"Yang K, Wu J, Li X (2008) Recent advances in the research of P-glycoprotein inhibitors. Biosci Trends 2:137\u2013146","journal-title":"Biosci Trends"},{"key":"7_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019329","volume":"6","author":"PR Ding","year":"2011","unstructured":"Ding PR, Tiwari AK, Ohnuma S, Lee JW, An X, Dai CL, Lu QS, Singh S, Yang DH, Talele TT, Ambudkar SV, Chen ZS (2011) The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1\/P-glycoprotein transporter. PLoS One 6, e19329","journal-title":"PLoS One"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.2174\/092986712800167392","volume":"19","author":"A Palmeira","year":"2012","unstructured":"Palmeira A, Sousa E, Vasconcelos MH, Pinto MM (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19:1946\u20132025","journal-title":"Curr Med Chem"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jep.2011.08.053","volume":"141","author":"T Eichhorn","year":"2012","unstructured":"Eichhorn T, Efferth T (2012) P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 141:557\u2013570","journal-title":"J Ethnopharmacol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2012.09.046","volume":"696","author":"H Zhu","year":"2012","unstructured":"Zhu H, Liu Z, Tang L, Liu J, Zhou M, Xie F, Wang Z, Wang Y, Shen S, Hu L, Yu L (2012) Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB\/VCR) cells. Eur J Pharmacol 696:43\u201353","journal-title":"Eur J Pharmacol"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bmc.2013.12.022","volume":"22","author":"S Munagala","year":"2014","unstructured":"Munagala S, Sirasani G, Kokkonda P, Phadke M, Krynetskaia N, Lu P, Sharom FJ, Chaudhury S, Abdulhameed MD, Tawa G, Wallqvist A, Martinez R, Childers W, Abou-Gharbia M, Krynetskiy E, Andrade RB (2014) Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. Bioorg Med Chem 22:1148\u20131155","journal-title":"Bioorg Med Chem"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5604\/17322693.1102278","volume":"68","author":"U Lewandowska","year":"2014","unstructured":"Lewandowska U, Gorlach S, Owczarek K, Hrabec E, Szewczyk K (2014) Synergistic interactions between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postepy Hig Med Dosw (Online) 68:528\u2013540","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2014.04.014","volume":"218","author":"C Martins","year":"2014","unstructured":"Martins C, Doran C, Silva IC, Miranda C, Rueff J, Rodrigues AS (2014) Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells. Chem Biol Interact 218:1\u20139","journal-title":"Chem Biol Interact"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13346-012-0079-x","volume":"3","author":"P Dandawate","year":"2013","unstructured":"Dandawate P, Padhye S, Ahmad A, Sarkar FH (2013) Novel strategies targeting cancer stem cells through phytochemicals and their analogs. Drug Deliv Transl Res 3:165\u2013182","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"7_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-013-9457-1","volume":"33","author":"BN Singh","year":"2014","unstructured":"Singh BN, Singh HB, Singh A, Naqvi AH, Singh BR (2014) Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev 33(1):41\u201385","journal-title":"Cancer Metastasis Rev"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/jphp.12097","volume":"65","author":"S Indumathy","year":"2013","unstructured":"Indumathy S, Dass CR (2013) Finding chemo: the search for marine-based pharmaceutical drugs active against cancer. J Pharm Pharmacol 65:1280\u20131301","journal-title":"J Pharm Pharmacol"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12033-012-9623-7","volume":"55","author":"T Khushnud","year":"2013","unstructured":"Khushnud T, Mousa SA (2013) Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer. Mol Biotechnol 55:78\u201386","journal-title":"Mol Biotechnol"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11888-012-0154-1","volume":"9","author":"B Aggarwal","year":"2013","unstructured":"Aggarwal B, Prasad S, Sung B, Krishnan S, Guha S (2013) Prevention and treatment of colorectal cancer by natural agents from mother nature. Curr Colorectal Cancer Rep 9:37\u201356","journal-title":"Curr Colorectal Cancer Rep"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/toxins2061207","volume":"2","author":"T Nabekura","year":"2010","unstructured":"Nabekura T (2010) Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins 2:1207\u20131224","journal-title":"Toxins"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1158\/1940-6207.CAPR-10-0098","volume":"4","author":"RE Carroll","year":"2011","unstructured":"Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 4:354\u2013364","journal-title":"Cancer Prev Res (Phila)"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2004.07.013","volume":"215","author":"T Dorai","year":"2004","unstructured":"Dorai T, Aggarwal BB (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett 215:129\u2013140","journal-title":"Cancer Lett"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1021\/jm300424n","volume":"55","author":"A Martins","year":"2012","unstructured":"Martins A, Toth N, Vanyolos A, Beni Z, Zupko I, Molnar J, Bathori M, Hunyadi A (2012) Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter. J Med Chem 55:5034\u20135043","journal-title":"J Med Chem"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbagen.2013.10.023","volume":"1840","author":"TH Kim","year":"2014","unstructured":"Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS (2014) Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochim Biophys Acta 1840:615\u2013625","journal-title":"Biochim Biophys Acta"},{"key":"7_CR34","first-page":"367","volume":"19","author":"N Gyemant","year":"2005","unstructured":"Gyemant N, Tanaka M, Antus S, Hohmann J, Csuka O, Mandoky L, Molnar J (2005) In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In Vivo 19:367\u2013374","journal-title":"In Vivo"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.intimp.2010.04.018","volume":"10","author":"G Du","year":"2010","unstructured":"Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M, Ji L, Lu L, Yu L, Han G (2010) Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. Int Immunopharmacol 10:819\u2013826","journal-title":"Int Immunopharmacol"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1097-0320(19971201)29:4<279::AID-CYTO3>3.0.CO;2-5","volume":"29","author":"A Krishan","year":"1997","unstructured":"Krishan A, Fitz CM, Andritsch I (1997) Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279\u2013285","journal-title":"Cytometry"},{"key":"7_CR37","first-page":"3989","volume":"29","author":"G Spengler","year":"2009","unstructured":"Spengler G, Ramalhete C, Martins M, Martins A, Serly J, Viveiros M, Molnar J, Duarte N, Mulhovo S, Ferreira MJ, Amaral L (2009) Evaluation of cucurbitane-type triterpenoids from Momordica balsamina on P-glycoprotein (ABCB1) by flow cytometry and real-time fluorometry. Anticancer Res 29:3989\u20133993","journal-title":"Anticancer Res"},{"key":"7_CR38","first-page":"2173","volume":"29","author":"G Spengler","year":"2009","unstructured":"Spengler G, Viveiros M, Martins M, Rodrigues L, Martins A, Molnar J, Couto I, Amaral L (2009) Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method. Anticancer Res 29:2173\u20132177","journal-title":"Anticancer Res"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.12.015","volume":"31","author":"M Viveiros","year":"2008","unstructured":"Viveiros M, Martins A, Paixao L, Rodrigues L, Martins M, Couto I, Fahnrich E, Kern WV, Amaral L (2008) Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 31:458\u2013462","journal-title":"Int J Antimicrob Agents"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/cyto.a.20067","volume":"60","author":"HM Shapiro","year":"2004","unstructured":"Shapiro HM (2004) \u201cCellular astronomy\u201d \u2013 a foreseeable future in cytometry. Cytometry A 60:115\u2013124","journal-title":"Cytometry A"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219\u2013234","journal-title":"Nat Rev Drug Discov"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1073\/pnas.85.12.4486","volume":"85","author":"I Pastan","year":"1988","unstructured":"Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci U S A 85:4486\u20134490","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.2910540317","volume":"54","author":"JL Weaver","year":"1993","unstructured":"Weaver JL, Szabo G Jr, Pine PS, Gottesman MM, Goldenberg S, Aszalos A (1993) The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int J Cancer 54:456\u2013461","journal-title":"Int J Cancer"},{"key":"7_CR44","first-page":"4867","volume":"30","author":"G Spengler","year":"2010","unstructured":"Spengler G, Evaristo M, Handzlik J, Serly J, Molnar J, Viveiros M, Kiec-Kononowicz K, Amaral L (2010) Biological activity of hydantoin derivatives on P-glycoprotein (ABCB1) of mouse lymphoma cells. Anticancer Res 30:4867\u20134871","journal-title":"Anticancer Res"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0021-9258(18)61633-3","volume":"262","author":"MM Cornwell","year":"1987","unstructured":"Cornwell MM, Pastan I, Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262:2166\u20132170","journal-title":"J Biol Chem"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/0959-8049(95)00288-T","volume":"31A","author":"S Koizumi","year":"1995","unstructured":"Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S (1995) Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123. Eur J Cancer 31A:1682\u20131688","journal-title":"Eur J Cancer"},{"key":"7_CR47","first-page":"3033","volume":"18","author":"J Molnar","year":"1998","unstructured":"Molnar J, Szabo D, Mandi Y, Mucsi I, Fischer J, Varga A, Konig S, Motohashi N (1998) Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res 18:3033\u20133038","journal-title":"Anticancer Res"},{"issue":"Pt 2","key":"7_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1042\/bj3170515","volume":"317","author":"S Orlowski","year":"1996","unstructured":"Orlowski S, Mir LM, Belehradek J Jr, Garrigos M (1996) Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J 317(Pt 2):515\u2013522","journal-title":"Biochem J"},{"key":"7_CR49","first-page":"1737","volume":"34","author":"G Spengler","year":"2014","unstructured":"Spengler G, Takacs D, Horvath A, Riedl Z, Hajos G, Amaral L, Molnar J (2014) Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells. Anticancer Res 34:1737\u20131741","journal-title":"Anticancer Res"}],"container-title":["Methods in Molecular Biology","Cancer Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3347-1_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T01:01:30Z","timestamp":1654390890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3347-1_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933457","9781493933471"],"references-count":49,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3347-1_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"25 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}